The UK parliament recently heard evidence on phages for AMR. According to Stephanie Lesage via LinkedIn: “There was a general consensus on the need to embrace the biological and unique nature of phages and find more suitable approaches to stringent GMP production, but also make regulations more flexible by adopting a more pragmatic framework to ensure phages/cocktails can be updated to follow epidemiological evolutions and the unique requirements of some patients.”